IFNB1 and myeloid sarcoma: In the mouse experimental auto-immune encephalomyelitis (EAE) model, modelling MS, the mechanism behind effective IFN-β treatment, was shown to be conferred through IFN-receptor-mediated induction of Socs1, which further attenuates activation of Rac1 and decreases the production of radical oxygen species (ROS).